517 related articles for article (PubMed ID: 30482770)
1. Clinical consequences of clonal hematopoiesis of indeterminate potential.
Steensma DP
Blood Adv; 2018 Nov; 2(22):3404-3410. PubMed ID: 30482770
[TBL] [Abstract][Full Text] [Related]
2. Clinical consequences of clonal hematopoiesis of indeterminate potential.
Steensma DP
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):264-269. PubMed ID: 30504320
[TBL] [Abstract][Full Text] [Related]
3. Telomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease.
Huang YC; Wang CY
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576030
[TBL] [Abstract][Full Text] [Related]
4. Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease.
Jaiswal S; Libby P
Nat Rev Cardiol; 2020 Mar; 17(3):137-144. PubMed ID: 31406340
[TBL] [Abstract][Full Text] [Related]
5. Clonal hematopoiesis and associated diseases: A review of recent findings.
Asada S; Kitamura T
Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
[TBL] [Abstract][Full Text] [Related]
6. Clonal hematopoiesis: Genes and underlying mechanisms in cardiovascular disease development.
Haybar H; Shahrabi S; Ghanavat M; Khodadi E
J Cell Physiol; 2019 Jun; 234(6):8396-8401. PubMed ID: 30417440
[TBL] [Abstract][Full Text] [Related]
7. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.
Sano S; Oshima K; Wang Y; Katanasaka Y; Sano M; Walsh K
Circ Res; 2018 Jul; 123(3):335-341. PubMed ID: 29728415
[TBL] [Abstract][Full Text] [Related]
8. Clonal hematopoiesis as determined by the HUMARA assay is a marker for acquired mutations in epigenetic regulators in older women.
Wiedmeier JE; Kato C; Zhang Z; Lee H; Dunlap J; Nutt E; Rattray R; McKay S; Eide C; Press R; Mori M; Druker B; Dao KH
Exp Hematol; 2016 Sep; 44(9):857-865.e5. PubMed ID: 27235757
[TBL] [Abstract][Full Text] [Related]
9. Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease.
Marnell CS; Bick A; Natarajan P
J Mol Cell Cardiol; 2021 Dec; 161():98-105. PubMed ID: 34298011
[TBL] [Abstract][Full Text] [Related]
10. Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions.
Singh I; Singh A
Curr Oncol Rep; 2023 Jun; 25(6):539-547. PubMed ID: 36928826
[TBL] [Abstract][Full Text] [Related]
11. Age-Associated
Ferrone CK; Blydt-Hansen M; Rauh MJ
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963585
[TBL] [Abstract][Full Text] [Related]
12. Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure.
Dorsheimer L; Assmus B; Rasper T; Ortmann CA; Ecke A; Abou-El-Ardat K; Schmid T; Brüne B; Wagner S; Serve H; Hoffmann J; Seeger F; Dimmeler S; Zeiher AM; Rieger MA
JAMA Cardiol; 2019 Jan; 4(1):25-33. PubMed ID: 30566180
[TBL] [Abstract][Full Text] [Related]
13. Atherosclerosis and clonal hematopoyesis: A new risk factor.
Páramo Fernández JA
Clin Investig Arterioscler; 2018; 30(3):133-136. PubMed ID: 29699715
[TBL] [Abstract][Full Text] [Related]
14. Somatic Mutations and Clonal Hematopoiesis: Unexpected Potential New Drivers of Age-Related Cardiovascular Disease.
Fuster JJ; Walsh K
Circ Res; 2018 Feb; 122(3):523-532. PubMed ID: 29420212
[TBL] [Abstract][Full Text] [Related]
15. [Clonal haematopoiesis: A concise review].
Danlos FX; Papo M; Micol JB
Rev Med Interne; 2019 Oct; 40(10):684-692. PubMed ID: 31126662
[TBL] [Abstract][Full Text] [Related]
16. Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD: JACC Review Topic of the Week.
Khetarpal SA; Qamar A; Bick AG; Fuster JJ; Kathiresan S; Jaiswal S; Natarajan P
J Am Coll Cardiol; 2019 Jul; 74(4):578-586. PubMed ID: 31345433
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic dysregulation of hematopoietic stem cells and preleukemic state.
Kunimoto H; Nakajima H
Int J Hematol; 2017 Jul; 106(1):34-44. PubMed ID: 28555413
[TBL] [Abstract][Full Text] [Related]
18. Aging drives Tet2+/- clonal hematopoiesis via IL-1 signaling.
Caiado F; Kovtonyuk LV; Gonullu NG; Fullin J; Boettcher S; Manz MG
Blood; 2023 Feb; 141(8):886-903. PubMed ID: 36379023
[TBL] [Abstract][Full Text] [Related]
19. Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk.
Haring B; Wissel S; Manson JE
Curr Cardiol Rep; 2022 Aug; 24(8):1049-1058. PubMed ID: 35657494
[TBL] [Abstract][Full Text] [Related]
20. DNMT3A clonal hematopoiesis-driver mutations induce cardiac fibrosis by paracrine activation of fibroblasts.
Shumliakivska M; Luxán G; Hemmerling I; Scheller M; Li X; Müller-Tidow C; Schuhmacher B; Sun Z; Dendorfer A; Debes A; Glaser SF; Muhly-Reinholz M; Kirschbaum K; Hoffmann J; Nagel E; Puntmann VO; Cremer S; Leuschner F; Abplanalp WT; John D; Zeiher AM; Dimmeler S
Nat Commun; 2024 Jan; 15(1):606. PubMed ID: 38242884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]